News Conference News ESC 2012 ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations Caitlin E. Cox September 04, 2012
News Conference News ESC 2012 Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients Caitlin E. Cox August 27, 2012
News Conference News ESC 2012 Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients August 26, 2012
News Industry News FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome May 23, 2012